Medical Oncology

, 31:148 | Cite as

Combined detection of serum exosomal miR-21 and HOTAIR as diagnostic and prognostic biomarkers for laryngeal squamous cell carcinoma

  • Jingting Wang
  • Yandong Zhou
  • Jianguang Lu
  • Yanan Sun
  • Hui Xiao
  • Ming LiuEmail author
  • Linli TianEmail author
Original Paper


Serum exosomes containing noncoding RNA (ncRNA) play an important role in both physiological and pathological conditions. However, biological function of exosomal ncRNA remains unclear. The aim of the study was to investigate the prognostic and diagnostic values of exosomal ncRNA by comparing the amounts of exosomal miR-21 and HOTAIR in serum of laryngeal squamous cell carcinoma (LSCC) patients with those of polyps of vocal cords, and by determinating whether combined detection of the two molecules could provide useful information in the diagnosis of LSCC. Exosomes were isolated from the serum samples of 52 LSCC patients and those of 49 patients with polyps of vocal cords. TEM and Western blot were applied for the confirmation of isolated exosomes by observing the ultra structure and testing CD63 marker protein, respectively. RT-PCR was performed to detect the expression of miR-21 and HOTAIR in the exosomes. The receiver-operating characteristic (ROC) curve was generated to examine the prognostic value of the two molecules. The expression of exosomal miR-21 and HOTAIR was significantly higher in patients with LSCC than those with vocal cord polyps. There were significant differences of serum exosomal miR-21 and HOTAIR expressions between the advanced T classifications (T3/T4) or clinical stages (III/IV) and the early stages. The patients with lymph node metastasis had higher serum exosomal miR-21 and HOTAIR expressions than those without. There were no differences between patient sex, tumor locations and differentiations. The area under the ROC curve of combined examination of exosomal HOTAIR and miR-21 for diagnosing LSCC was 87.6 %, which was significantly higher than 80.1 % of miR-21 (p = 0.0359) or 72.7 % of HOTAIR (p = 0.0012), showing 94.2 and 73.5 % of sensitivity and specificity, respectively, in differentiating the malignant from benign laryngeal disease. Serum exosomal miR-21 and HOTAIR were significantly correlated with clinical parameters of LSCC, and combined evaluation of their serum expressions may be a valuable biomarker to screen LSCC and might be a promising predicting tool for LSCC patient.


Exosome HOTAIR MiR-21 Laryngeal squamous cell carcinoma 



The research was supported by Grants from the Heilongjiang Postdoctoral Fund (LBH-Z12157), the foundation of Heilongjiang Educational Committee (12531343), the foundation of Heilongjiang Health Bureau (2012-624), the Doctor Foundation of the Second Affiliated Hospital of Harbin Medical University (BS2013-15), the National science Foundation of china (81372902, 81272965, 81241085), the Natural Science Foundation of Heilongjiang Province of China (QC2013C117, ZD201215), the Research Fund for the Doctoral Program of Higher Education of China (20102307110007), the Chinese Postdoctoral Science Foundation (2014M551276), the science and technology innovation talent research funds of Harbin (2012RFXXS072).

Conflict of interest

The authors declare that they have no conflict of interest.


  1. 1.
    Chu EA, Kim YJ. Laryngeal cancer: diagnosis and preoperative work-up. Otolaryngol Clin North Am. 2008;41(4):673–95.PubMedCrossRefGoogle Scholar
  2. 2.
    Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62(1):10–29. doi: 10.3322/caac.20138.PubMedCrossRefGoogle Scholar
  3. 3.
    Boyle P, Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann Oncol. 2005;16(3):481–8.PubMedCrossRefGoogle Scholar
  4. 4.
    Bissell MJ, Radisky DC, Rizki A, Weaver VM, Petersen OW. The organizing principle: microenvironmental influences in the normal and malignant breast. Differentiation. 2002;70(9–10):537–46.PubMedCrossRefPubMedCentralGoogle Scholar
  5. 5.
    Dayan D, Salo T, Salo S, Nyberg P, Nurmenniemi S, Costea DE, et al. Molecular crosstalk between cancer cells and tumor microenvironment components suggests potential targets for new therapeutic approaches in mobile tongue cancer. Cancer Med. 2012;1(2):128–40.PubMedCrossRefPubMedCentralGoogle Scholar
  6. 6.
    Stoorvogel W, Kleijmeer MJ, Geuze HJ, Raposo G. The biogenesis and functions of exosomes. Traffic. 2002;3(5):321–30.PubMedCrossRefGoogle Scholar
  7. 7.
    Dear JW, Street JM, Bailey MA. Urinary exosomes: a reservoir for biomarker discovery and potential mediators of intrarenal signalling. Proteomics. 2013;13(10–11):1572–80.PubMedCrossRefGoogle Scholar
  8. 8.
    Gallo A, Tandon M, Alevizos I, Illei GG. The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS One. 2012;7(3):e30679.PubMedCrossRefPubMedCentralGoogle Scholar
  9. 9.
    Zhang HG, Grizzle WE. Exosomes and cancer: a newly described pathway of immune suppression. Clin Cancer Res. 2011;17(5):959–64.PubMedCrossRefPubMedCentralGoogle Scholar
  10. 10.
    Esteller M. Non-coding RNAs in human disease. Nat Rev Genet. 2011;12(12):861–74.PubMedCrossRefGoogle Scholar
  11. 11.
    Tian L, Li M, Ge J, Guo Y, Sun Y, Liu M, et al. MiR-203 is downregulated in laryngeal squamous cell carcinoma and can suppress proliferation and induce apoptosis of tumours. Tumour Biol. 2014;35(6):5953–63.Google Scholar
  12. 12.
    Tian L, Zhang J, Ge J, Xiao H, Lu J, Fu S, et al. MicroRNA-205 suppresses proliferation and promotes apoptosis in laryngeal squamous cell carcinoma. Med Oncol. 2014;31(1):785.PubMedCrossRefGoogle Scholar
  13. 13.
    Zhang T, Han G, Wang Y, Chen K, Sun Y. MicroRNA expression profiles in supraglottic carcinoma. Oncol Rep. 2014;31(5):2029–34.PubMedGoogle Scholar
  14. 14.
    Ren J, Zhu D, Liu M, Sun Y, Tian L. Downregulation of miR-21 modulates Ras expression to promote apoptosis and suppress invasion of Laryngeal squamous cell carcinoma. Eur J Cancer. 2010;46(18):3409–16.PubMedCrossRefGoogle Scholar
  15. 15.
    Li M, Tian L, Wang L, Yao H, Zhang J, Lu J, et al. Down-Regulation of miR-129-5p Inhibits Growth and Induces Apoptosis in Laryngeal Squamous Cell Carcinoma by Targeting APC. PLoS One. 2013;8(10):e77829.PubMedCrossRefPubMedCentralGoogle Scholar
  16. 16.
    Li D, Feng J, Wang Y, Sun Y, Ren J, Liu M. Long intergenic noncoding RNA HOTAIR is overexpressed and regulates PTEN methylation in laryngeal squamous cell carcinoma. Am J Pathol. 2013;182(1):64–70.PubMedCrossRefGoogle Scholar
  17. 17.
    Memczak S, Jens M, Elefsinioti A, Torti F, Krueger J, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495(7441):333–8.PubMedCrossRefGoogle Scholar
  18. 18.
    Takeshita N, Hoshino I, Mori M, Akutsu Y, Hanari N, Yoneyama Y, et al. Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma. Br J Cancer. 2013;108(3):644–52.PubMedCrossRefPubMedCentralGoogle Scholar
  19. 19.
    Guenzel T, Franzen A, Wiegand S, Kraetschmer S, Jahn JL, Mironczuk R, et al. The value of PET compared to MRI in malignant head and neck tumors. Anticancer Res. 2013;33(3):1141–6.PubMedGoogle Scholar
  20. 20.
    Becker M, Zaidi H. Imaging in head and neck squamous cell carcinoma: the potential role of PET/MRI. Br J Radiol. 2014;87(1036):20130677.PubMedCrossRefGoogle Scholar
  21. 21.
    Johnson JT, Branstetter BF 4th. PET/CT in head and neck oncology: state-of-the-art 2013. Laryngoscope. 2014;124(4):913–5.PubMedCrossRefGoogle Scholar
  22. 22.
    Reid G, Kirschner MB, van Zandwjk N. Circulating microRNAs: Association with disease and potential use as biomarkers. Crit Rev Oncol Hematol. 2011;80(2):193–208.PubMedCrossRefGoogle Scholar
  23. 23.
    Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, Lee MJ, et al. The microRNA spectrum in 12 body fluids. Clin Chem. 2010;56(11):1733–41.PubMedCrossRefGoogle Scholar
  24. 24.
    Ohshima K, Inoue K, Fujiwara A, Hatakeyama K, Kanto K, Watanabe Y, et al. Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line. PLoS One. 2010;5(10):e13247.PubMedCrossRefPubMedCentralGoogle Scholar
  25. 25.
    Zhang Y, Liu D, Chen X, Li J, Li L, Bian Z, et al. Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell. 2010;39(1):133–44.PubMedCrossRefGoogle Scholar
  26. 26.
    Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, Pulford K, et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol. 2008;141(5):672–5.PubMedCrossRefGoogle Scholar
  27. 27.
    Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP, Wei WI. Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res. 2008;14(9):2588–92.PubMedCrossRefGoogle Scholar
  28. 28.
    King HW, Michael MZ, Gleadle JM. Hypoxic enhancement of exosome release by breast cancer cells. BMC Cancer. 2012;12:421.PubMedCrossRefPubMedCentralGoogle Scholar
  29. 29.
    Aushev VN, Zborovskaya IB, Laktionov KK, Girard N, Cros MP, Herceg Z, et al. Comparisons of microRNA patterns in plasma before and after tumor removal reveal new biomarkers of lung squamous cell carcinoma. PloS One. 2013;8(10):e78649.PubMedCrossRefPubMedCentralGoogle Scholar
  30. 30.
    Kobayashi M, Salomon C, Tapia J, Illanes SE, Mitchell MD, Rice GE. Ovarian cancer cell invasiveness is associated with discordant exosomal sequestration of Let-7miRNA and miR-200. J Transl Med. 2014;12:4.Google Scholar
  31. 31.
    Westermann AM, Schmidt D, Holdenrieder S, Moritz R, Semjonow A, Schmidt M, et al. Serum microRNAs as biomarkers in patients undergoing prostate biopsy: results from a prospective multi-center study. Anticancer Res. 2014;34(2):665–9.PubMedGoogle Scholar
  32. 32.
    Yang Y, Gu X, Zhou M, Xiang J, Chen Z. Serum microRNAs: a new diagnostic method for colorectal cancer. Biomed Rep. 2013;1(4):495–8.PubMedPubMedCentralGoogle Scholar
  33. 33.
    Kosaka N, Iguchi H, Ochiya T. Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci. 2010;101(10):2087–92.PubMedCrossRefGoogle Scholar
  34. 34.
    Ratajczak J, Wysoczynski M, Hayek F, Janowska-Wieczorek A, Ratajczak MZ. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia. 2006;20(9):1487–95.PubMedCrossRefGoogle Scholar
  35. 35.
    Tanaka Y, Kamohara H, Kinoshita K, Kurashige J, Ishimoto T, Iwatsuki M, et al. Clinical impact of serum exosomal microRNA-21 as a clinical biomarker in human esophageal squamous cell carcinoma. Cancer. 2013;119(6):1159–67.PubMedCrossRefGoogle Scholar
  36. 36.
    Parikh VN, Chan SY. Analysis of microRNA niches: techniques to measure extracellular microRNA and intracellular microRNA in situ. Methods Mol Biol. 2013;1024:157–72.PubMedCrossRefPubMedCentralGoogle Scholar
  37. 37.
    Huang X, Yuan T, Tschannen M, Sun Z, Jacob H, Du M, et al. Characterization of human plasma-derived exosomal RNAs by deep sequencing. BMC Genom. 2013;10(14):319.CrossRefGoogle Scholar
  38. 38.
    Théry C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol. 2009;9(8):581–93.PubMedCrossRefGoogle Scholar
  39. 39.
    Jørgensen M, Bæk R, Pedersen S, Søndergaard EK, Kristensen SR, Varming K. Extracellular Vesicle (EV) Array: microarray capturing of exosomes and other extracellular vesicles for multiplexed phenotyping. J Extracell Vesicles. 2013;18:2.Google Scholar
  40. 40.
    Rekker K, Saare M, Roost AM, Kubo AL, Zarovni N, Chiesi A, et al. Comparison of serum exosome isolation methods for microRNA profiling. Clin Biochem. 2014;47(1–2):135–8.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Department of Otorhinolaryngology, Head and Neck Surgery, Second Affiliated HospitalHarbin Medical UniversityHarbinChina

Personalised recommendations